(Sharecast News) - Haleon said on Friday that it has agreed to buy an additional 33% interest in Tianjin TSKF Pharmaceutical - its joint venture in China - from its partners Tianjin Pharmaceutical Group (TPG) and Tianjin Pharmaceutical Da Ren Tang Group Corporation (DRTG) for RMB4,465m (circa£0.5bn).

The consumer health...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE